je.st
news
Tag: update
Division Streetscape Project Update: December 3, 2014
2014-12-04 17:49:37| PortlandOnline
Environmental Services and the Portland Bureau of Transportation have completed sewer, stormwater and transportation improvements in your area. The new sewers, green street planters and transportation enhancements will contribute to a more livable and sustainable community and serve residents and businesses in the neighborhood for many years.
Tags: december
project
update
division
UPDATE 2-GSK cuts U.S. research and sales jobs as market gets tougher
2014-12-04 12:30:56| Biotech - Topix.net
GlaxoSmithKline is to shed hundreds of U.S. commercial and research jobs, restructuring operations in its biggest market where drug sales are flagging. A total of 900 posts will be eliminated at GSK's Research Triangle Park site in North Carolina as drug research is consolidated in Philadelphia and in Stevenage, near London, according to a filing with the North Carolina Department of Commerce.
Tags: research
jobs
sales
market
UPDATE 2-Aeropostale to shut 75 stores as sales continue to fall
2014-12-04 03:01:53| Apparel - Topix.net
Teen apparel retailer Aeropostale Inc reported its eight straight quarterly loss, hurt by higher discounts and falling demand, and said it would close about 75 stores in the current quarter. Traditional retailers in North America have been forced to slash prices to fight off intense competition and try to win back customers who increasingly prefer shopping online.
Tags: to
sales
continue
stores
SADIF Analytics releases new rating update reports for USA stocks
2014-12-03 16:00:17| Livestock - Topix.net
Ilhavo, Portugal - SADIF Investment Analytics, announces a new rating update report covering the following companies: Report Summary for: Fletcher Building Limited is a below average quality company with a neutral outlook. Fletcher Building Limited has medium business growth and is run by efficient management.
Tags: usa
rating
reports
update
UPDATE 1-Bayer to seek approval for haemophilia drug this month
2014-12-03 03:55:36| Chemicals - Topix.net
Drugmaker Bayer AG said on Tuesday it will this month file for approval of its experimental haemophilia drug Bay 81-8973, based on its established Kogenate brand, as it seeks to build a range of treatments against the hereditary bleeding disorder. The German company in March unveiled plans to spend more than 500 million euros to set up haemophilia drug production sites in Germany, in a sign of confidence in its development pipeline.
Tags: month
update
drug
approval
Sites : [653] [654] [655] [656] [657] [658] [659] [660] [661] [662] [663] [664] [665] [666] [667] [668] [669] [670] [671] [672] next »